|
| |
Guide to Screening for an
Unknown Drug or Poison
-
There are no simple tests that
are able to detect all of the drugs and other
poisons that might have been ingested by a
patient. A wide variety of substances may be
involved, which include: gases, volatile liquids,
inorganic metal salts, pharmaceutical products,
illicit drugs, herbicides and pesticides.
Patients may also ingest cocktails of substances
with or without alcohol. Patients from overseas
may have access to pharmaceutical and herbal
products that are not commonly available in the
U.K. Investigations for an "unknown"
drug or poison are usually carried out on
specimens of urine (30 mL for qualitative
tests) and blood (10 mL for qualitative
and quantitative tests) and undertaken on a 24
hour basis. Stomach aspirate may sometimes be
useful, as are the contents of bottles or tablet
containers so called "scene
residues". Most investigations are done on
an emergency basis and completed within 2 hours.
The rapid turnaround time is important if
investigations are to influence acute patient
management. When carrying out these
investigations it is of great importance that the
laboratory is aware of the patient history,
findings from the clinical examination of the
patient, and the results of other investigation.
A close liaison between the requesting physician
and the laboratory is an important requirement
for providing an efficient laboratory service.
Those clinical situations where toxicological
investigations may be useful are listed in Table
1. In general, investigations should be only
requested if they are likely to aid diagnosis or
influence the management of the patient.
Specimens required for
carrying out laboratory investigations for the
detection of an unknown drug or poison:
Urine: 30 mL
(Sterilin container). NO PRESERVATIVE.
Note: do not add any
preservative e.g. boric acid.
Blood:
10 mL heparinised (avoid gel
containing tubes if possible). Smaller
specimen volumes may be accepted for
paediatric cases.
Stomach
contents: Stomach contents and
washout are not normally
required for screening purposes, unless
they are found to contain intact tablets,
capsules or other material that may be
easily identified.
It is important to write the full
name of the patient on each specimen container also
the date and time of collection. It is
advisable to collect specimens as soon as possible
following admission, prior to treatment. Each request
should come with a properly completed request card
giving sufficient background information and
indicating the nature of the investigation required,
also the name and bleep number of the requesting
doctor.
-
Please always contact the
laboratory BEFORE sending any specimens and
discuss the case with a senior member of the
laboratory staff:
Dr Stephen George,
Clinical Toxicology Section Head: 0121 507 6029
Other senior staff: 0121 507
4135/6
It is important to establish
the full available history on a patient before
making a request.
-
If there is delay in the transport
of specimens to the Laboratory they should be kept at
4°C in a refrigerator. Specimens of blood should be
in secure containers and enclosed in individual
plastic bags, suitably packed in a rigid box. DO
NOT SEND SPECIMENS IN JIFFY BAGS OR USE STAPLES.
If investigations are required urgently specimens
should be transported to the Laboratory by taxi or
appropriate rapid transport. IT IS IMPORTANT TO
ALWAYS RING THE LABORATORY BEFORE SENDING URGENT
SPECIMENS.
-
In most cases there is
important information concerning the patient that is
useful to the Laboratory. Such history includes:-
 | Patients
occupation and likely access to specific drugs or
poisons.
|
 | Relevant
previous medical history e.g. psychiatric history
or diseases such as epilepsy that may indicate
the availability of certain types of medication.
|
 | Date and time of
alleged ingestion in relation to admission to
hospital.
|
 | Drugs previously
prescribed to the patient or accessible in the
home; this latter point is particularly important
in cases of paediatric poisoning.
|
 | Clinical
examination of the patient and specific signs and
symptoms of poisoning.
|
 | Ingestion of
alcohol. The consumption of very large quantities
of alcohol may cause deep coma in some cases. It
is useful to indicate if the patient smells of
alcohol or other substances on the breath e.g.
acetone, which could suggest other problems e.g.
ketoacidosis.
|
 | Results of any
biochemical or haematological investigations
carried out on admission e.g. blood, glucose,
electrolytes and gases.
|
 | Results of any
toxicological investigations already carried out
by a local laboratory e.g. salicylate,
paracetamol.
|
 | All drugs given
in treatment since admission, including
antidotes, antibiotics and anaesthetic agents.
(Note: many of these substances will be detected
by the screening procedure and if not declared
may hinder the interpretation of results).
|
-
There are a number of
biochemical and haematological that may indicate
a diagnosis of poisoning. Many of these changes
are non-specific, but may indicate the ingestion
of certain agents that can be investigated by the
screening procedures.
-
It would be impossible to
screen for all substances that
might have been ingested by a patient. It is
always important to discuss the required scope of
the investigations when requesting an
unknown drug screen. The
standard screening procedure carried
out is designed to look for those substances most
commonly ingested by patients and likely to cause
harm. The screen also seeks to confirm (or
refute) the ingestion of substances that the
patient is thought to have ingested or had access
to.

TABLE 1
CLINICAL
SITUATIONS WHERE TOXICOLOGICAL INVESTIGATIONS MAY BE
USEFUL
- Assessment of the severity of
poisoning (quantitative analyses)
- Where a diagnosis of poisoning
is uncertain, particularly in children
- Differential diagnosis of coma
- Where administration of an
antidote depends on the rapid identification of a
poison and its concentration in
blood
- The prognosis of complications
or fatal outcome to poisoning
- To monitor the efficacy of an
active elimination technique or antidote.
- Investigation of
non-accidental poisoning in children, e.g.
"child abuse" or Münchausens
Syndrome by Proxy.
- Confirmation of substance or
drug misuse
- Investigation of new drugs or
an unusual clinical presentation
- Investigation of adverse drug
reactions and iatrogenic poisoning
- The confirmation of brain
death
- Occupational or environmental
exposure to chemicals including chemical
accidents

TABLE 2
POINTS
TO CONSIDER WHEN REQUESTING A DRUG SCREEN
- History of Patient
- Signs and symptoms of
poisoning
- Laboratory and other
investigations already carried out
- Drugs given in treatment since
admission (written list)
- Will the analysis influence
diagnosis or management?
- How urgent is the request?
- Date and time of ingestion in
relation to presentation in hospital
- Date of time of specimens in
relation to admission
- Transport of specimens in
Laboratory
- Name and bleep number of
requesting physician for reporting urgent results
- Any medico-legal issues
- Scope of the investigations to
be carried out

SPECIFIC SUBSTANCES
AND GROUPS OF DRUGS AND EXAMPLES OF SPECIFIC SUBSTANCES
WHICH MAY BE DETECTED IN URINE*
| GROUP |
EXAMPLES |
| |
|
| Alcohols
(and acetone) |
Ethanol,
methanol, isopropanol |
| Salicylate |
Aspirin,
methylsalicylate |
| Paracetamol
|
Paracetamol |
| Benzodiazepines
|
Diazepam,
temazepam |
| Barbiturates
|
Phenobarbitone,
amylobarbitone, quinalbarbitone |
| Amphetamines
+ sympathomimetics |
Amphetamines,
ephedrine, MDMA ("Ecstasy"), MDA, MDEA |
| Opiates
|
Codeine,
morphine, dihydrocodeine |
| Opioids
|
Methadone,
dextropropoxyphene, pethidine |
| Tricyclic
and related antidepressants |
Dothiepin,
imipramine, amitriptyline |
| Other
antidepressants |
Fluvoxamine,
fluoxetine, trazadone, tranylcypromine,
trazadone,venlafaxine,
citalopram, paroxetine, sertraline |
| ß-blockers
(some) |
Propranolol,
timolol |
| Anti-arrhythmics
|
Verapamil,
disopyramide |
| Antimalarials
|
Quinine,
chloroquine |
| Anti-Parkinsonism
drugs |
Procyclidine,
orphenadrine |
| Phenothiazines
|
Chlorpromazine,
thioridazine |
| Anticonvulsants
|
Phenytoin,
carbamazepine |
| Pheniramines
and some other antihistamines |
Chlorpheniramine,
diphenhydramine, mequitazine, promethazine,
cyclizine |
| Trichloro-compounds
|
Chloral,
(trichloroethylene) |
| Miscellaneous
|
Chlormethiazole,
nefopam, trimethoprim, zopiclone, metoclopramide |
*Ethanol will also be measured
quantitatively provided that a suitable blood or urine
specimen is provided.
NOTES:
- The "turn-around-time"
for an urgent "standard" qualitative
drug screen is normally 1-2 hours from the
receipt of the specimen by the Laboratory.
(Please note that surcharges for
"within-hours" urgent requests and
out-of-hours requests are made).
- An extended description
of the Unknown Drug Screening procedure may be
obtained form the laboratory upon request.
- Minimum sample
requirements: 30ml Urine + 10ml Blood (see also
the table of Assay
Availability & Sample Requirement)
- More extensive
drug/poison screening tests and quantitative
analyses may be carried out on individual cases,
depending on the history and clinical
indications. These additional tests include:
cyanide, glycols, diuretics, chlorphenoxy
herbicides, laxatives, paraquat, volatile
solvents and gases, heavy metals etc.

Last
modified: June 16, 2005
Copyright ©
[Regional Laboratory for Toxicology], 2002. All rights
reserved.
|